SCHEMBL17797705

SCHEMBL17797705

O=[N+]([O-])c1ccc2c(c1)CN(C1CCC1)CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
ADRA2A P08913 1/20 0.44
PNMT P11086 1/20 0.44
AKR1C3 P42330 1/20 0.43
CPT2 P23786 1/20 0.43
CPT1A P50416 1/20 0.43
HRH3 Q9Y5N1 4/20 0.42
GRIN2B Q13224 3/20 0.42
GRIN1 Q05586 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
DRD2 P14416 1/20 0.41
CYP2D6 P10635 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17797589 0.94 PNMT (0.47) ALDH1A1MAPTSMN1; SMN2NPC1POLB
SCHEMBL4764965 0.92 HRH3 (0.50) ALDH1A1MAPTSMN1; SMN2NPC1POLB
SCHEMBL28292439 0.89 AKR1C3 (0.45) ALDH1A1MAPTSMN1; SMN2NPC1POLB
SCHEMBL30612409 0.89 AKR1C3 (0.45) ALDH1A1MAPTSMN1; SMN2NPC1POLB
SCHEMBL1950958 0.85 MEN1 (0.49) MAPTRAB9AADRA2APNMTHRH3
SCHEMBL30561533 0.85 PNMT (0.43) ALDH1A1MAPTSMN1; SMN2POLBADRA2A
SCHEMBL20704027 0.85 PNMT (0.43) ALDH1A1MAPTSMN1; SMN2POLBADRA2A
Hydrochloric Acid SCHEMBL7467008 0.84 MEN1 (0.48) MAPTRAB9AADRA2APNMTHRH3
SCHEMBL30612412 0.84 ACHE (0.44) ALDH1A1MAPTSMN1; SMN2NPC1POLB
Hydrochloric Acid SCHEMBL7507958 0.82 NPC1 (0.45) ALDH1A1MAPTSMN1; SMN2NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE CAR LLC (BM) 2016-06-09 US disclosed
WO-2016090079-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-06-09 WO disclosed
WO-2016090079-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159774-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 ALDH1A1 684/4885MAPT 1888/4885SMN1; SMN2 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.